Episode 077: Management of relapsed diffuse l...

This week, we are so excited to share the first of our Career Development Series episodes, developed in partnership with The American Society of Hematology , The ASH Trainee Council, and Hematopoiesis! For years, our listeners have reached out to our show asking for guidance to h ...  Show more

This week, we begin our discussion about treatment of multiple myeloma, focusing on the first-line setting. Once again, a lot has changed in this space over the last few years, most notably the standards of care (now quadruplet regimens instead of triplet regimens!). We break dow ...  Show more

This is the last episode of our core curriculum series. In this episode we discuss cancer survivorship as it relates to gynecologic oncology. Additionally we provide a framework for surveillance visits as well the general timing based on primary malignancy. We also give a brief o ...  Show more

In this podcast, I continue our discussion of the Step 3 Free 137. If you’re taking Step 2CK, I highly recommend listening to this podcast. I discuss a lot of complex concepts and useful test taking tips. Lengthy, but well worth the listening time. Use the PDF on the USMLE websit ...  Show more

I accidentally posted episode 3 BEFORE I updated episode 2 and I am ashamed and disgusted with this sad fact. Here's the biology episode I missed.

RESOURCES: <a href="https://news.harvard.edu/gazette/story/2022/06/bonobos-tolerant-peaceful-group-relationships-paved- ...

Join Jame and Callum as they discuss this paper which examines where these new antibiotics are going, and why they aren't widely available.Notes for this episode here Support the showWe are currently seeking more detailed feedback, please help us improve the podcast by giving you ...  Show more